Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: Geriatric medicine, General practice / family medicine, UK, Neurology

NICE reȷects Alzheimer’s drug donanemab owing to cost and “significant health risks”

The National Institute for Health and Care Excellence (NICE) has rejected the Alzheimer’s drug donanemab because the “relatively […]

October 24, 2024 Geriatric medicine, General practice / family medicine, UK, Neurology
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy